Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Degar, James"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł :
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.
Autorzy :
Pouliot, Gayle P. (AUTHOR)
Degar, James (AUTHOR)
Hinze, Laura (AUTHOR)
Kochupurakkal, Bose (AUTHOR)
Vo, Chau D. (AUTHOR)
Burns, Melissa A. (AUTHOR)
Moreau, Lisa (AUTHOR)
Ganesa, Chirag (AUTHOR)
Roderick, Justine (AUTHOR)
Peirs, Sofie (AUTHOR)
Menten, Bjorn (AUTHOR)
Loh, Mignon L. (AUTHOR)
Hunger, Stephen P. (AUTHOR)
Silverman, Lewis B. (AUTHOR)
Harris, Marian H. (AUTHOR)
Stevenson, Kristen E. (AUTHOR)
Weinstock, David M. (AUTHOR)
Weng, Andrew P. (AUTHOR)
Van Vlierberghe, Pieter (AUTHOR)
D'Andrea, Alan D. (AUTHOR)
Pokaż więcej
Źródło :
PLoS ONE. 11/13/2019, Vol. 14 Issue 11, p1-22. 22p.
Czasopismo naukowe
Tytuł :
Inducible Phase Separation of GSK3α As a Mechanism for Asparaginase Resistance in Acute Leukemias
Autorzy :
Hinze, Laura
Schreek, Sabine
Zeug, Andre
Ponimaskin, Evgeni
Labrosse, Roxane
Degar, James
Chiosis, Gabriela
Pai, Sung-Yun
Stevenson, Kristen E.
Neuberg, Donna S
Bornhauser, Beat
Bourquin, Jean-Pierre
Stanulla, Martin
Gutierrez, Alejandro
Pokaż więcej
Źródło :
Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p169-169, 1p
Periodyk
Tytuł :
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.
Autorzy :
Ariës IM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Bodaar K; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Karim SA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Chonghaile TN; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Deparment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Hinze L; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Burns MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Pfirrmann M; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Degar J; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Landrigan JT; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Balbach S; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, University Hospital Muenster, Muenster, Germany.
Peirs S; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Menten B; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Isenhart R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
Neuberg DS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
Devidas M; Department of Biostatistics, University of Florida, Gainesville, FL.
Loh ML; Department of Pediatrics, University of California San Francisco, San Francisco, CA.
Hunger SP; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Teachey DT; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Rabin KR; Division of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.
Winter SS; Cancer and Blood Disorders Department, Children's Minnesota, Minneapolis, MN.
Dunsmore KP; Department of Pediatrics, Carilion Children's, Roanoke, VA.
Wood BL; Department of Laboratory Medicine, University of Washington, Seattle, WA.
Silverman LB; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Sallan SE; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Van Vlierberghe P; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Orkin SH; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Howard Hughes Medical Institute, Boston, MA.
Knoechel B; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Letai AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Gutierrez A; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA .; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2018 Dec 03; Vol. 215 (12), pp. 3094-3114. Date of Electronic Publication: 2018 Nov 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Apoptosis*
Drug Resistance, Neoplasm*
Neoplasm Proteins/*metabolism
Polycomb Repressive Complex 2/*metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*metabolism
Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Leukemic/drug effects ; Humans ; Male ; Mitochondria/genetics ; Mitochondria/metabolism ; Mitochondria/pathology ; Neoplasm Proteins/genetics ; Polycomb Repressive Complex 2/genetics ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Transcription, Genetic/drug effects ; Up-Regulation/drug effects
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies